Thomas Garner
EVP, Chief Commercial Officer · ACADIA PHARMACEUTICALS INC
Individual
- 2024
- Mar 10, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas Garner files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark C. Schneyer - $1.13M in ACAD purchases and sales in the last 12 months
- James M. Daly - $671K in ACAD purchases and sales in the last 12 months
- James Kihara - $603K in ACAD purchases and sales in the last 12 months
- Elizabeth H.Z. Thompson - $506K in ACAD purchases and sales in the last 12 months
- Adams Catherine Owen - $250K in ACAD purchases and sales in the last 12 months
- Jennifer J. Rhodes - $245K in ACAD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas Garner?
Thomas Garner is a corporate insider, tracked as EVP, Chief Commercial Officer of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Thomas Garner last file a Form 4?
The most recent primary Form 4 on record is dated 10 March 2026, one of 2 filings going back to 2024.